Medicinal plants and phytochemicals against multidrug-resistant tumor cells expressing ABCB1, ABCG2, or ABCB5: a synopsis of 2 decades

Abdelfatah SA, Efferth T (2015) Cytotoxicity of the indole alkaloid reserpine from Rauwolfia serpentina against drug-resistant tumor cells. Phytomedicine 22(2):308–318

Abdelfatah S, Berg A, Böckers M, Efferth T (2018) A selective inhibitor of the Polo-box domain of Polo-like kinase 1 identified by virtual screening. J Adv Res 16:145–156

Abdelfatah S, Fleischer E, Klinger A, Wong VKW, Efferth T (2020a) Identification of inhibitors of the polo-box domain of polo-like kinase 1 from natural and semisynthetic compounds. Invest New Drugs 38(1):1–9

Adams M, Mahringer A, Bauer R, Fricker G, Efferth T (2007a) In vitro cytotoxicity and P-glycoprotein modulating effects of geranylated furocoumarins from Tetradium daniellii. Planta Med 73(14):1475–1478

Adams M, Mahringer A, Kunert O, Fricker G, Efferth T, Bauer R (2007b) Cytotoxicity and p-glycoprotein modulating effects of quinolones and indoloquinazolines from the Chinese herb Evodia rutaecarpa. Planta Med 73(15):1554–1557

Adem FA, Kuete V, Mbaveng AT, Heydenreich M, Ndakala A, Irungu B, Efferth T, Yenesew A (2018) Cytotoxic benzylbenzofuran derivatives from Dorstenia kameruniana. Fitoterapia 128:26–30

Adem FA, Kuete V, Mbaveng AT, Heydenreich M, Koch A, Ndakala A, Irungu B, Yenesew A, Efferth T (2019a) Cytotoxic flavonoids from two Lonchocarpus species. Nat Prod Res 33(18):2609–2617

Adem FA, Mbaveng AT, Kuete V, Heydenreich M, Ndakala A, Irungu B, Yenesew A, Efferth T (2019b) Cytotoxicity of isoflavones and biflavonoids from Ormocarpum kirkii towards multi-factorial drug resistant cancer. Phytomedicine 58:152853

Amaral L, Spengler G, Molnar J (2016) Identification of important compounds isolated from natural sources that have activity against multidrug-resistant cancer cell lines: effects on proliferation, apoptotic mechanism and the efflux pump responsible for multi-resistance phenotype. Anticancer Res 36(11):5665–5672

Amiri-Kordestani L, Fojo T (2012) Why do phase III clinical trials in oncology fail so often? J Natl Cancer Inst 104(8):568–569 [Erratum in: J Natl Cancer Inst 2012;104(11):885]

Ashidi JS, Houghton PJ, Hylands PJ, Efferth T (2010) Ethnobotanical survey and cytotoxicity testing of plants of South-western Nigeria used to treat cancer, with isolation of cytotoxic constituents from Cajanus cajan Millsp. leaves. J Ethnopharmacol 128(2):501–512

Assaraf YG, Brozovic A, Gonçalves AC, Jurkovicova D, Linē A, Machuqueiro M, Saponara S, Sarmento-Ribeiro AB, Xavier CPR, Vasconcelos MH (2019) The multi-factorial nature of clinical multidrug resistance in cancer. Drug Resist Updat 46:100645

Bayat Mokhtari R, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, Yeger H (2017) Combination therapy in combating cancer. Oncotarget 8(23):38022–38043

Bell SE, Quinn DM, Kellett GL, Warr JR (1998) 2-Deoxy-d-glucose preferentially kills multidrug-resistant human KB carcinoma cell lines by apoptosis. Br J Cancer 78:1464–1470

Bentley J, Quinn DM, Pitman RS, Warr JR, Kellett GL (1997) The human KB multidrug-resistant cell line KB-C1 is hypersensitive to inhibitors of glycosylation. Cancer Lett 115:221–227

Biedler JL, Chang TD, Meyers MB, Peterson RH, Spengler BA (1983) Drug resistance in Chinese hamster lung and mouse tumor cells. Cancer Treat Rep 67(10):859–867

Bolisetty S, Jaimes EA (2013) Mitochondria and reactive oxygen species: physiology and pathophysiology. Int J Mol Sci 14(3):6306–6344

Borst P, Schinkel AH (1997) Genetic dissection of the function of mammalian P-glycoproteins. Trends Genet 13(6):217–222

Bringmann G, Seupel R, Feineis D, Zhang G, Xu M, Wu J, Kaiser M, Brun R, Seo EJ, Efferth T (2016) Ancistectorine D, a naphthylisoquinoline alkaloid with antiprotozoal and antileukemic activities, and further 5,8′- and 7,1′-linked metabolites from the Chinese liana Ancistrocladus tectorius. Fitoterapia 115:1–8

Bringmann G, Seupel R, Feineis D, Xu M, Zhang G, Kaiser M, Brun R, Seo EJ, Efferth T (2017) Antileukemic ancistrobenomine B and related 5,1′-coupled naphthylisoquinoline alkaloids from the Chinese liana Ancistrocladus tectorius. Fitoterapia 121:76–85

Brown GC (1992) Control of respiration and ATP synthesis in mammalian mitochondria and cells. Biochem J 284:1–13

Broxterman HJ, Pinedo HM, Kuiper CM, Kaptein LC, Schuurhuis GJ, Lankelma J (1988) Induction by verapamil of a rapid increase in ATP consumption in multidrug-resistant tumor cells. FASEB J 2:2278–2282

Çapcı Karagöz A, Reiter C, Seo EJ, Gruber L, Hahn F, Leidenberger M, Klein V, Hampel F, Friedrich O, Marschall M, Kappes B, Efferth T, Tsogoeva SB (2018) Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisinin. Bioorg Med Chem 26(12):3610–3618

Chen KG, Szakács G, Annereau JP, Rouzaud F, Liang XJ, Valencia JC, Nagineni CN, Hooks JJ, Hearing VJ, Gottesman MM (2005) Principal expression of two mRNA isoforms (ABCB 5alpha and ABCB 5beta) of the ATP-binding cassette transporter gene ABCB 5 in melanoma cells and melanocytes. Pigment Cell Res 18(2):102–112

Chen KG, Valencia JC, Gillet JP, Hearing VJ, Gottesman MM (2009) Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma. Pigment Cell Melanoma Res 22(6):740–749

Cheung ST, Cheung PF, Cheng CK, Wong NC, Fan ST (2011) Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance. Gastroenterology 140(1):344–355

Chong CC, Cheung ST, Cheung YS, Chan AW, Chan SL, Yu SC, Lai PB (2018) Novel biomarkers GEP/ABCB5 regulate response to adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 17(6):524–530

Dal Piaz F, Terracciano S, De Tommasi N, Braca A (2015) Hsp90 activity modulation by plant secondary metabolites. Planta Med 81(14):1223–1239

Dawood M, Ooko E, Efferth T (2019) Collateral sensitivity of parthenolide via NF-κB and HIF-α inhibition and epigenetic changes in drug-resistant cancer cell lines. Front Pharmacol 10:542

Doyle L, Ross DD (2003) Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22(47):7340–7358

Du GY, He SW, Zhang L, Sun CX, Mi LD, Sun ZG (2018) Hesperidin exhibits in vitro and in vivo antitumor effects in human osteosarcoma MG-63 cells and xenograft mice models via inhibition of cell migration and invasion, cell cycle arrest and induction of mitochondrial-mediated apoptosis. Oncol Lett 16(5):6299–6306

Eadie LN, Hughes TP, White DL (2014) Interaction of the efflux transporters ABCB1 and ABCG2 with imatinib, nilotinib, and dasatinib. Clin Pharmacol Ther 95(3):294–306

Efferth T (2019) Biopiracy of medicinal plants: finding fair solutions for the use of natural resources. Phytomedicine 53:294–295

Efferth T, Koch E (2011) Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr Drug Targets 12(1):122–132

Efferth T, Volm M (1993) Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms. Cancer Lett 70(3):197–202

Efferth T, Volm M (2004) Protein expression profiles indicative for drug resistance of kidney carcinoma. Cancer Genom Proteom 1(1):17–22

Efferth T, Volm M (2017) Multiple resistance to carcinogens and xenobiotics: P-glycoproteins as universal detoxifiers. Arch Toxicol 91(7):2515–2538

Efferth T, Davey M, Olbrich A, Rücker G, Gebhart E, Davey R (2002a) Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. Blood Cells Mol Dis 28(2):160–168

Efferth T, Miyachi H, Drexler HG, Gebhart E (2002b) Methylthioadenosine phosphorylase as target for chemoselective treatment of T-cell acute lymphoblastic leukemic cells. Blood Cells Mol Dis 28(1):47–56

Efferth T, Olbrich A, Sauerbrey A, Ross DD, Gebhart E, Neugebauer M (2002c) Activity of ascaridol from the anthelmintic herb Chenopodium anthelminticum L. against sensitive and multidrug-resistant tumor cells. Anticancer Res 22(6C):4221–4224

Efferth T, Gillet JP, Sauerbrey A, Zint IF, Bertholet V, de Longueville F, Remacle J, Steinbach D (2006) Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia. Mol Cancer Ther 5(8):1986–1994

Efferth T, Kahl S, Paulus K, Adams M, Rauh R, Boechzelt H, Hao X, Kaina B, Bauer R (2008a) Phytochemistry and pharmacogenomics of natural products derived from traditional Chinese medicine and Chinese materia medica with activity against tumor cells. Mol Cancer Ther 7(1):152–161

Efferth T, Konkimalla VB, Wang YF, Sauerbrey A, Meinhardt S, Zintl F, Mattern J, Volm M (2008b) Prediction of broad spectrum resistance of tumors towards anticancer drugs. Clin Cancer Res 14(8):2405–2412

Efferth T, Herrmann F, Tahrani A, Wink M (2011) Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin. Phytomedicine 18(11):959–969

Efferth T, Zeino M, Volm M (2015) Modulation of P-glycoprotein-mediated multidrug resistance by synthetic and phytochemical small molecules, monoclonal antibodies, and therapeutic nucleic acids. In: Efferth T (ed) Resistance to targeted ABC transporters in cancer, resistance to targeted anti-cancer therapeutics, vol 4. Springer, Switzerland, pp 153–181

Efferth T, Banerjee M, Paul NW, Abdelfatah S, Arend J, Elhassan G, Hamdoun S, Hamm R, Hong C, Kadioglu O, Naß J, Ochwangi D, Ooko E, Ozenver N, Saeed ME, Schneider M, Seo EJ, Wu CF, Yan G, Zeino M, Zhao Q, Abu-Darwish MS, Andersch K, Alexie G, Bessarab D, Bhakta-Guha D, Bolzani V, Dapat E, Donenko FV, Efferth M, Greten HJ, Gunatilaka L, Hussein AA, Karadeniz A, Khalid HE, Kuete V, Lee IS, Liu L, Midiwo J, Mora R, Nakagawa H, Ngassapa O, Noysang C, Omosa LK, Roland FH, Shahat AA, Saab A, Saeed EM, Shan L, Titinchi SJ (2016) Biopiracy of natural products and good bioprospecting practice. Phytomedicine 23(2):166–173

Efferth T, Saeed MEM, Kadioglu O, Seo EJ, Shirooie S, Mbaveng AT, Nabavi SM, Kuete V (2020) Collateral sensitivity of natural products in drug-resistant cancer cells. Biotechnol Adv 38:107382

Eichhorn T, Efferth T (2012) P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs. J Ethnopharmacol 141(2):557–570

Farawela HM, Khorshied MM, Kassem NM, Kassem HA, Zawam HM (2014) The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study. J Cancer Res Clin Oncol 140(8):1323–1330

Fayez S, Feineis D, Mudogo V, Seo EJ, Efferth T, Bringmann G (2018) Ancistrolikokine I and further 5,8′-coupled naphthylisoquinoline alkaloids from the Congolese liana Ancistrocladus likoko and their cytotoxic activities against drug-sensitive and multidrug resistant human leukemia cells. Fitoterapia 129:114–125

Ferreira M, Costa J, Reis-Henriques MA (2014a) ABC transporters in fish species: a review. Front Physiol 5:266

Ferreira M, Santos P, Rey-Salgueiro L, Zaja R, Reis-Henriques MA, Smital T (2014b) The first demonstration of CYP1A and the ABC protein(s) gene expression and activity in European seabass (Dicentrarchus labrax) primary hepatocytes. Chemosphere 100:152–159

Fiskus W, Rao R, Fernandez P, Herger B, Yang Y, Chen J, Kolhe R, Mandawat A, Wang Y, Joshi R, Eaton K, Lee P, Atadja P, Peiper S, Bhalla K (2008) Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells. Blood 112:2896–2905

Fletcher JI, Williams RT, Henderson MJ, Norris MD, Haber M (2016) ABC transporters as mediators of drug resistance and contributors to cancer cell biology. Drug Resist Updat 26:1–9

Formisano C, Sirignano C, Rigano D, Chianese G, Zengin G, Seo EJ, Efferth T, Taglialatela-Scafati O (2017) Antiproliferative activity against leukemia cells of sesquiterpene lactones from the Turkish endemic plant Centaurea drabifolia subsp. detonsa. Fitoterapia 120:98–102

Fotso WG, Na-Iya J, Mbaveng TA, Ango Yves P, Demirtas I, Kuete V, Samuel Y, Ngameni B, Efferth T, Ngadjui TB (2019) Polyacanthoside A, a new oleanane-type triterpenoid saponin with cytotoxic effects from the leaves of Acacia polyacantha (Fabaceae). Nat Prod Res 33(24):3521–3526

Frank NY, Margaryan A, Huang Y, Schatton T, Waaga-Gasser AM, Gasser M, Sayegh MH, Sadee W, Frank MH (2005) ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 65(10):4320–4333

Fröhlich T, Reiter C, Ibrahim MM, Beutel J, Hutterer C, Zeitträger I, Bahsi H, Leidenberger M, Friedrich O, Kappes B, Efferth T, Marschall M, Tsogoeva SB (2017a) Synthesis of novel hybrids of quinazoline and artemisinin with high activities against Plasmodium falciparum, human cytomegalovirus, and leukemia cells. ACS Omega 2(6):2422–2431

Fröhlich T, Reiter C, Saeed MEM, Hutterer C, Hahn F, Leidenberger M, Friedrich O, Kappes B, Marschall M, Efferth T, Tsogoeva SB (2017b) Synthesis of thymoquinone-artemisinin hybrids: new potent antileukemia, antiviral, and antimalarial agents. ACS Med Chem Lett 9(6):534–539

Fukaya M, Nakamura S, Hegazy MEF, Sugimoto Y, Hayashi N, Nakashima S, Yoshikawa M, Efferth T, Matsuda H (2018) Cytotoxicity of sesquiterpene alkaloids from Nuphar plants toward sensitive and drug-resistant cell lines. Food Funct 9(12):6279–6286

Furman WL, McGregor LM, McCarville MB, Onciu M, Davidoff AM, Kovach S, Hawkins D, McPherson V, Houghton PJ, Billups CA, Wu J, Stewart CF, Santana VM (2012) A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma. Invest New Drugs 30(4):1660–1670

Gillet JP, Efferth T, Remacle J (2007) Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochim Biophys Acta 1775(2):237–262

Gottesman MM, Ling V (2006) The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 580(4):998–1009

Grimm M, Krimmel M, Polligkeit J, Alexander D, Munz A, Kluba S, Keutel C, Hoffmann J, Reinert S, Hoefert S (2012) ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma. Eur J Cancer 48(17):3186–3197

Gruber L, Abdelfatah S, Fröhlich T, Reiter C, Klein V, Tsogoeva SB, Efferth T (2018) Treatment of multidrug-resistant leukemia cells by novel artemisinin-, egonol-, and thymoquinone-derived hybrid compounds. Molecules 23(4):E841

Gupta SC, Prasad S, Sethumadhavan DR, Nair MS, Mo YY, Aggarwal BB (2013) Nimbolide, a limonoid triterpene, inhibits growth of human colorectal cancer xenografts by suppressing the proinflammatory microenvironment. Clin Cancer Res 19(16):4465–4476

Ha JS, Byun J, Ahn DR (2016) Overcoming doxorubicin resistance of cancer cells by Cas9-mediated gene disruption. Sci Rep 6:22847

Hall MD, Handley MD, Gottesman MM (2009) Is resistance useless? Multidrug resistance and collateral sensitivity. Trends Pharmacol Sci 30(10):546–556

Hamdoun S, Fleischer E, Klinger A, Efferth T (2017a) Lawsone derivatives target the Wnt/β-catenin signaling pathway in multidrug-resistant acute lymphoblastic leukemia cells. Biochem Pharmacol 146:63–73

Hamdoun S, Jung P, Efferth T (2017b) Drug repurposing of the anthelmintic niclosamide to treat multidrug-resistant leukemia. Front Pharmacol 8:110

Hamm R, Sugimoto Y, Steinmetz H, Efferth T (2014) Resistance mechanisms of cancer cells to the novel vacuolar H+-ATPase inhibitor archazolid B. Invest New Drugs 32(5):893–903

Hari M, Loganzo F, Annable T, Tan X, Musto S, Morilla DB, Nettles JH, Snyder JP, Greenberger LM (2006) Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules. Mol Cancer Ther 2006(5):270–278

Hegazy MF, Hamed AR, El-Halawany AM, Hussien TA, Abdelfatah S, Ohta S, Paré PW, Abdel-Sattar E, Efferth T (2018) Cytotoxicity of abietane diterpenoids from Salvia multicaulis towards multidrug-resistant cancer cells. Fitoterapia 130:54–60

Hegazy MF, Abdelfatah S, Hamed AR, Mohamed TA, Elshamy AA, Saleh IA, Reda EH, Abdel-Azim NS, Shams KA, Sakr M, Sugimoto Y, Paré PW, Efferth T (2019a) Cytotoxicity of 40 Egyptian plant extracts targeting mechanisms of drug-resistant cancer cells. Phytomedicine 59:152771

Hegazy MF, Fukaya M, Dawood M, Yan G, Klinger A, Fleischer E, Zaglool AW, Efferth T (2019b) Vitamin K3 thio-derivative: a novel specific apoptotic inducer in the doxorubicin-sensitive and -resistant cancer cells. Invest New Drugs 38:650–661

Hegedus C, Ozvegy-Laczka C, Apáti A, Magócsi M, Német K, Orfi L, Kéri G, Katona M, Takáts Z, Váradi A, Szakács G, Sarkadi B (2009) Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties. Br J Pharmacol 158(4):1153–1164

Hira D, Terada T (2018) BCRP/ABCG2 and high-alert medications: biochemical, pharmacokinetic, pharmacogenetic, and clinical implications. Biochem Pharmacol 147:201–210

Horwedel C, Tsogoeva SB, Wei S, Efferth T (2010) Cytotoxicity of artesunic acid homo- and heterodimer molecules toward sensitive and multidrug-resistant CCRF-CEM leukemia cells. J Med Chem 53(13):4842–4848

Jensen PB, Holm B, Sorensen M, Christensen IJ, Sehested M (1997) In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin. Br J Cancer 75(6):869–877

Jones PM, George AM (2005) Multidrug resistance in parasites: ABC transporters, P-glycoproteins and molecular modelling. Int J Parasitol 35(5):555–566

Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455(1):152–162

Kadioglu O, Cao J, Kosyakova N, Mrasek K, Liehr T, Efferth T (2016) Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance. Sci Rep 6:36754

Kadioglu O, Chan A, Cong Ling Qiu A, Wong VKW, Colligs V, Wecklein S, Freund-Henni Rached H, Efferth T, Hsiao WW (2017) Artemisinin derivatives target topoisomerase 1 and cause DNA damage in silico and in vitro. Front Pharmacol 8:711

Kadioglu O, Saeed M, Kuete V, Greten HJ, Efferth T (2018) Oridonin targets multiple drug-resistant tumor cells as determined by in silico and in vitro analyses. Front Pharmacol. 16(9):355

Kaplan O, Jaroszewski JW, Clarke R, Fairchild CR, Schoenlein P, Goldenberg S, Gottesman MM, Cohen JS (1991) The multidrug resistance phenotype: 31P nuclear magnetic resonance characterization and 2-deoxyglucose toxicity. Cancer Res 51:1638–1644

Karadeniz A, Alexie G, Greten HJ, Andersch K, Efferth T (2015) Cytotoxicity of medicinal plants of the West-Canadian Gwich' in Native Americans towards sensitive and multidrug-resistant cancer cells. J Ethnopharmacol 168:191–200

Karwatsky J, Lincoln MC, Georges E (2003) A mechanism for P-glycoprotein-mediated apoptosis as revealed by verapamil hypersensitivity. Biochemistry 42:12163–12173

Kerr ID, Jones PM, George AM (2010) Multidrug efflux pumps: the structures of prokaryotic ATP-binding cassette transporter efflux pumps and implications for our understanding of eukaryotic P-glycoproteins and homologues. FEBS J 277(3):550–563

Kessel D, Botterill V, Wodinsky I (1968) Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response. Cancer Res 28(5):938–941

Kotoh S, Naito S, Yokomizo A, Kumazawa J, Asakuno K, Kohno K, Kuwano M (1994) Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells. Cancer Res 54(12):3248–3252

Krieger J, Smeilus T, Kaiser M, Seo EJ, Efferth T, Giannis A (2018) Total synthesis and biological investigation of (-)-artemisinin: the antimalarial activity of artemisinin is not stereospecific. Angew Chem Int Ed Engl 57(27):8293–8296

Kuete V, Krusche B, Youns M, Voukeng I, Fankam AG, Tankeo S, Lacmata S, Efferth T (2011a) Cytotoxicity of some Cameroonian spices and selected medicinal plant extracts. J Ethnopharmacol 134(3):803–812

Kuete V, Ngameni B, Wiench B, Krusche B, Horwedel C, Ngadjui BT, Efferth T (2011b) Cytotoxicity and mode of action of four naturally occuring flavonoids from the genus Dorstenia: gancaonin Q, 4-hydroxylonchocarpin, 6-prenylapigenin, and 6,8-diprenyleriodictyol. Planta Med 77(18):1984–1989

Kuete V, Wiench B, Hegazy ME, Mohamed TA, Fankam AG, Shahat AA, Efferth T (2012) Antibacterial activity and cytotoxicity of selected Egyptian medicinal plants. Planta Med 78(2):193–199

Kuete V, Fankam AG, Wiench B, Efferth T (2013a) Cytotoxicity and modes of action of the methanol extracts of six cameroonian medicinal plants against multidrug-resistant tumor cells. Evid Based Complement Alternat Med 2013:285903

Kuete V, Sandjo LP, Wiench B, Efferth T (2013b) Cytotoxicity and modes of action of four Cameroonian dietary spices ethno-medically used to treat cancers: Echinops giganteus, Xylopia aethiopica, Imperata cylindrica and Piper capense. J Ethnopharmacol 149(1):245–253

Kuete V, Voukeng IK, Tsobou R, Mbaveng AT, Wiench B, Beng VP, Efferth T (2013c) Cytotoxicity of Elaoephorbia drupifera and other Cameroonian medicinal plants against drug sensitive and multidrug resistant cancer cells. BMC Complement Altern Med 13:250

Kuete V, Wiench B, Alsaid MS, Alyahya MA, Fankam AG, Shahat AA, Efferth T (2013d) Cytotoxicity, mode of action and antibacterial activities of selected Saudi Arabian medicinal plants. BMC Complement Altern Med 13:354

Kuete V, Ango PY, Yeboah SO, Mbaveng AT, Mapitse R, Kapche GD, Ngadjui BT, Efferth T (2014a) Cytotoxicity of four Aframomum species (A. arundinaceum, A. alboviolaceum, A. kayserianum and A. polyanthum) towards multi-factorial drug resistant cancer cell lines. BMC Complement Altern Med 14:340

Kuete V, Nkuete AH, Mbaveng AT, Wiench B, Wabo HK, Tane P, Efferth T (2014b) Cytotoxicity and modes of action of 4′-hydroxy-2′,6′-dimethoxychalcone and other flavonoids toward drug-sensitive and multidrug-resistant cancer cell lines. Phytomedicine 21(12):1651–1657

Kuete V, Sandjo LP, Djeussi DE, Zeino M, Kwamou GM, Ngadjui B, Efferth T (2014c) Cytotoxic flavonoids and isoflavonoids from Erythrina sigmoidea towards multi-factorial drug resistant cancer cells. Invest New Drugs 32(6):1053–1062

Kuete V, Sandjo LP, Kwamou GM, Wiench B, Nkengfack AE, Efferth T (2014d) Activity of three cytotoxic isoflavonoids from Erythrina excelsa and Erythrina senegalensis (neobavaisoflavone, sigmoidin H and isoneorautenol) toward multi-factorial drug resistant cancer cells. Phytomedicine 21(5):682–688

Kuete V, Sandjo LP, Ouete JL, Fouotsa H, Wiench B, Efferth T (2014e) Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines. Phytomedicine 21(3):315–322

Kuete V, Tankeo SB, Saeed ME, Wiench B, Tane P, Efferth T (2014f) Cytotoxicity and modes of action of five Cameroonian medicinal plants against multi-factorial drug resistance of tumor cells. J Ethnopharmacol 153(1):207–219

Kuete V, Donfack AR, Mbaveng AT, Zeino M, Tane P, Efferth T (2015a) Cytotoxicity of anthraquinones from the roots of Pentas schimperi towards multi-factorial drug-resistant cancer cells. Invest New Drugs 33(4):861–869

Kuete V, Fouotsa H, Mbaveng AT, Wiench B, Nkengfack AE, Efferth T (2015b) Cytotoxicity of a naturally occurring furoquinoline alkaloid and four acridone alkaloids towards multi-factorial drug-resistant cancer cells. Phytomedicine 22(10):946–951

Kuete V, Mbaveng AT, Zeino M, Ngameni B, Kapche GD, Kouam SF, Ngadjui BT, Efferth T (2015c) Cytotoxicity of two naturally occurring flavonoids (dorsmanin F and poinsettifolin B) towards multi-factorial drug-resistant cancer cells. Phytomedicine 22(7–8):737–743

Kuete V, Saeed ME, Kadioglu O, Börtzler J, Khalid H, Greten HJ, Efferth T (2015d) Pharmacogenomic and molecular docking studies on the cytotoxicity of the natural steroid wortmannin against multidrug-resistant tumor cells. Phytomedicine 22(1):120–127

Kuete V, Sandjo LP, Mbaveng AT, Seukep JA, Ngadjui BT, Efferth T (2015e) Cytotoxicity of selected Cameroonian medicinal plants and Nauclea pobeguinii towards multi-factorial drug-resistant cancer cells. BMC Complement Altern Med 15:309

Kuete V, Sandjo LP, Mbaveng AT, Zeino M, Efferth T (2015f) Cytotoxicity of compounds from Xylopia aethiopica towards multi-factorial drug-resistant cancer cells. Phytomedicine 22(14):1247–1254

Kuete V, Sandjo LP, Seukep JA, Zeino M, Mbaveng AT, Ngadjui B, Efferth T (2015g) Cytotoxic compounds from the fruits of Uapaca togoensis towards multifactorial drug-resistant cancer cells. Planta Med 81(1):32–38

Kuete V, Dzotam JK, Voukeng IK, Fankam AG, Efferth T (2016a) Cytotoxicity of methanol extracts of Annona muricata, Passiflora edulis and nine other Cameroonian medicinal plants towards multi-factorial drug-resistant cancer cell lines. Springerplus 5(1):1666

Kuete V, Mbaveng AT, Nono EC, Simo CC, Zeino M, Nkengfack AE, Efferth T (2016b) Cytotoxicity of seven naturally occurring phenolic compounds towards multi-factorial drug-resistant cancer cells. Phytomedicine 23(8):856–863

Kuete V, Tchinda CF, Mambe FT, Beng VP, Efferth T (2016c) Cytotoxicity of methanol extracts of 10 Cameroonian medicinal plants towards multi-factorial drug-resistant cancer cell lines. BMC Complement Altern Med 16:267

Kuete V, Mbaveng AT, Sandjo LP, Zeino M, Efferth T (2017) Cytotoxicity and mode of action of a naturally occurring naphthoquinone, 2-acetyl-7-methoxynaphtho[2,3-b]furan-4,9-quinone towards multi-factorial drug-resistant cancer cells. Phytomedicine 33:62–68

Kuppens IE, Witteveen EO, Jewell RC, Radema SA, Paul EM, Mangum SG, Beijnen JH, Voest EE, Schellens JH (2007) A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients. Clin Cancer Res 13(11):3276–3285

Kwamou GM, Sandjo LP, Kuete V, Wandja AA, Tankeo SB, Efferth T, Nkengfack AE (2015) Unprecedented new nonadecyl para-hydroperoxycinnamate isolated from Erythrina excelsa and its cytotoxic activity. Nat Prod Res 29(10):921–925

Laberge RM, Karwatsky J, Lincoln MC, Leimanis ML, Georges E (2007) Modulation of GSH levels in ABCC1 expressing tumor cells triggers apoptosis through oxidative stress. Biochem Pharmacol 73(11):1727–1737

Laberge RM, Ambadipudi R, Georges E (2009) P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil. Arch Biochem Biophys 91:53–60

Lee CG, Gottesman MM, Cardarelli CO, Ramachandra M, Jeang KT, Ambudkar SV, Pastan I, Dey S (1998) HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry 37(11):3594–3601

Letis AS, Seo EJ, Nikolaropoulos SS, Efferth T, Giannis A, Fousteris MA (2017) Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells. Bioorg Med Chem 25(13):3357–3367

Li J, Seupel R, Feineis D, Mudogo V, Kaiser M, Brun R, Brünnert D, Chatterjee M, Seo EJ, Efferth T, Bringmann G (2017) Dioncophyllines C2, D2, and F and related naphthylisoquinoline alkaloids from the Congolese liana Ancistrocladus ileboensis with potent activities against Plasmodium falciparum and against multiple myeloma and leukemia cell lines. J Nat Prod 80(2):443–458

Lorendeau D, Dury L, Genoux-Bastide E, Lecerf-Schmidt F, Simões-Pires C, Carrupt PA, Terreux R, Magnard S, Di Pietro A, Boumendiel A, Baubichon-Cortay H (2014) Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux. Biochem Pharmacol 90(3):235–245

Lucia MB, Rutella S, Leone G, Vella S, Cauda R (2001) HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART. J Acquir Immune Defic Syndr 27(4):321–330

Ma J, Lin JY, Alloo A, Wilson BJ, Schatton T, Zhan Q, Murphy GF, Waaga-Gasser AM, Gasser M, Stephen Hodi F, Frank NY, Frank MH (2010) Isolation of tumorigenic circulating melanoma cells. Biochem Biophys Res Commun 402(4):711–717

Mahmoud N, Saeed MEM, Sugimoto Y, Klauck SM, Greten HJ, Efferth T (2018) Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation. Oncotarget 9(87):35762–35779

Mahmoud N, Saeed MEM, Sugimoto Y, Klinger A, Fleischer E, Efferth T (2020) Putative molecular determinants mediating sensitivity or resistance towards carnosic acid tumor cell responses. Phytomedicine (in press)

Mahringer A, Karamustafa S, Klotz D, Kahl S, Konkimalla VB, Wang Y, Wang J, Liu HY, Boechzelt H, Hao X, Bauer R, Fricker G, Efferth T (2010) Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine. Cancer Genomics Proteom 7(4):191–205

Marie JP, Legrand O (1999) MDR1/P-GP expression as a prognostic factor in acute leukemias. Adv Exp Med Biol 457:1–9

Mbaveng AT, Fotso GW, Ngnintedo D, Kuete V, Ngadjui BT, Keumedjio F, Andrae-Marobela K, Efferth T (2018a) Cytotoxicity of epunctanone and four other phytochemicals isolated from the medicinal plants Garcinia epunctata and Ptycholobium contortum towards multi-factorial drug resistant cancer cells. Phytomedicine 48:112–119

Mbaveng AT, Manekeng HT, Nguenang GS, Dzotam JK, Kuete V, Efferth T (2018b) Cytotoxicity of 18 Cameroonian medicinal plants against drug sensitive and multi-factorial drug resistant cancer cells. J Ethnopharmacol 222:21–33

Mbaveng AT, Ndontsa BL, Kuete V, Nguekeu YMM, Çelik İ, Mbouangouere R, Tane P, Efferth T (2018c) A naturally occurring triterpene saponin ardisiacrispin B displayed cytotoxic effects in multi-factorial drug resistant cancer cells via ferroptotic and apoptotic cell death. Phytomedicine 43:78–85

Mbaveng AT, Damen F, Çelik İ, Tane P, Kuete V, Efferth T (2019a) Cytotoxicity of the crude extract and constituents of the bark of Fagara tessmannii towards multi-factorial drug resistant cancer cells. J Ethnopharmacol 235:28–37

Mbaveng AT, Damen F, Simo Mpetga JD, Awouafack MD, Tane P, Kuete V, Efferth T (2019b) Cytotoxicity of crude extract and isolated constituents of the Dichrostachys cinerea bark towards multifactorial drug-resistant cancer cells. Evid Based Complement Alternat Med 2019:8450158

Mbaveng AT, Damen F, Fofack MGG, Tankeo SB, Abdelfatah S, Bitchagno GTM, Çelik I, Kuete V, Efferth T (2020) 8,8-bis-(Dihydroconiferyl)-diferulate displayed impressive cytotoxicity towards a panel of human and animal cancer cells. Phytomedicine 70:153215

Mealey KL, Fidel J (2015) P-glycoprotein mediated drug interactions in animals and humans with cancer. J Vet Intern Med 29(1):1–6

Merola VM, Eubig PA (2012) Toxicology of avermectins and milbemycins (macrocylic lactones) and the role of P-glycoprotein in dogs and cats. Vet Clin North Am Small Anim Pract 42(2):313–333

Molnár J, Engi H, Hohmann J, Molnár P, Deli J, Wesolowska O, Michalak K, Wang Q (2010) Reversal of multidrug resistance by natural substances from plants. Curr Top Med Chem 10(17):1757–1768

Myllynen P, Kummu M, Sieppi E (2010) ABCB1 and ABCG2 expression in the placenta and fetus: an interspecies comparison. Expert Opin Drug Metab Toxicol 6(11):1385–1398

Nabekura T (2010) Overcoming multidrug resistance in human cancer cells by natural compounds. Toxins (Basel) 2(6):1207–1224

Nare B, Prichard RK, Georges E (1994) Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells. Mol Pharmacol 45(6):1145–1152

Natarajan K, Baer MR, Ross DD (2015) Role of breast cancer resistance protein (BCRP, ABCG2) in cancer outcomes and drug resistance. In: Efferth T (ed) Resistance to targeted ABC transporters in cancer, resistance to targeted anti-cancer therapeutics, vol 4. Springer, Switzerland, pp 153–181

Newman DJ, Cragg GM (2016) Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79(3):629–661

Nganou BK, Mbaveng AT, Fobofou SAT, Fankam AG, Bitchagno GTM, Simo Mpetga JD, Wessjohann LA, Kuete V, Efferth T, Tane P (2019) Furoquinolines and dihydrooxazole alkaloids with cytotoxic activity from the stem bark of Araliopsis soyauxii. Fitoterapia 133:193–199

Nielsen DL, Palshof JA, Brünner N, Stenvang J, Viuff BM (2017) Implications of ABCG2 expression on irinotecan treatment of colorectal cancer patients: a review. Int J Mol Sci 18(9):E1926

Nkuété AH, Kuete V, Gozzini D, Migliolo L, Oliveira AL, Wabo HK, Tane P, Vidari G, Efferth T, Franco OL (2015) Anti-leukemia activity of semi-synthetic phenolic derivatives from Polygonum limbatum Meisn. Chem Cent J 9:40

O’Donnell MJ (2009) Too much of a good thing: how insects cope with excess ions or toxins in the diet. J Exp Biol 212(Pt 3):363–372

Ochwang’i DO, Kimwele CN, Oduma JA, Gathumbi PK, Kiama SG, Efferth T (2018) Cytotoxic activity of medicinal plants of the Kakamega County (Kenya) against drug-sensitive and multidrug-resistant cancer cells. J Ethnopharmacol 215:233–240

O’Driscoll L, Clynes M (2006) Biomarkers and multiple drug resistance in breast cancer. Curr Cancer Drug Targets 6(5):365–384

Omosa LK, Mbogo GM, Korir E, Omole R, Seo EJ, Yenesew A, Heydenreich M, Midiwo JO, Efferth T (2019) Cytotoxicity of fagaramide derivative and canthin-6-one from Zanthoxylum (Rutaceae) species against multidrug resistant leukemia cells. Nat Prod Res 21:1–8

Onwujekwe O, Agwu P, Orjiakor C, McKee M, Hutchinson E, Mbachu C, Odii A, Ogbozor P, Obi U, Ichoku H, Balabanova D (2019) Corruption in Anglophone West Africa health systems: a systematic review of its different variants and the factors that sustain them. Health Policy Plan 34(7):529–543

Ooko E, Alsalim T, Saeed B, Saeed MEM, Kadioglu O, Abbo HS, Titinchi SJJ, Efferth T (2016) Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines. Toxicol Appl Pharmacol 305:216–233

Ooko E, Kadioglu O, Greten HJ, Efferth T (2017) Pharmacogenomic characterization and isobologram analysis of the combination of ascorbic acid and curcumin—two main metabolites of Curcuma longa—in cancer cells. Front Pharmacol 8:38

Orelle C, Mathieu K, Jault JM (2019) Multidrug ABC transporters in bacteria. Res Microbiol 170(8):381–391

Özenver N, Saeed M, Demirezer LÖ, Efferth T (2018) Aloe-emodin as drug candidate for cancer therapy. Oncotarget 9(25):17770–17796

Peña-Solórzano D, Stark SA, König B, Sierra CA, Ochoa-Puentes C (2017) ABCG2/BCRP: specific and nonspecific modulators. Med Res Rev 37(5):987–1050

Pieterse P, Lodge T (2015) When free healthcare is not free. Corruption and mistrust in Sierra Leone’s primary healthcare system immediately prior to the Ebola outbreak. Int Health 7(6):400–404

Pluchino KM, Hall MD, Goldsborough AS, Callaghan R, Gottesman MM (2012) Collateral sensitivity as a strategy against cancer multidrug resistance. Drug Resist Update 15(1–2):98–105

Prasad R, Goffeau A (2012) Yeast ATP-binding cassette transporters conferring multidrug resistance. Annu Rev Microbiol 66:39–63

Reid AL, Millward M, Pearce R, Lee M, Frank MH, Ireland A, Monshizadeh L, Rai T, Heenan P, Medic S, Kumarasinghe P, Ziman M (2013) Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression. Br J Dermatol 168(1):85–92

Reiter C, Capcı Karagöz A, Fröhlich T, Klein V, Zeino M, Viertel K, Held J, Mordmüller B, Emirdağ Öztürk S, Anıl H, Efferth T, Tsogoeva SB (2014) Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells. Eur J Med Chem 75:403–412

Reiter C, Fröhlich T, Gruber L, Hutterer C, Marschall M, Voigtländer C, Friedrich O, Kappes B, Efferth T, Tsogoeva SB (2015a) Highly potent artemisinin-derived dimers and trimers: synthesis and evaluation of their antimalarial, antileukemia and antiviral activities. Bioorg Med Chem 23(17):5452–5458

Reiter C, Fröhlich T, Zeino M, Marschall M, Bahsi H, Leidenberger M, Friedrich O, Kappes B, Hampel F, Efferth T, Tsogoeva SB (2015b) New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids. Eur J Med Chem 97:164–172

Riordan JR, Ling V (1985) Genetic and biochemical characterization of multidrug resistance. Pharmacol Ther 28(1):51–75

Rispel LC, de Jager P, Fonn S (2016) Exploring corruption in the South African health sector. Health Policy Plan 31(2):239–249

Roninson IB, Chin JE, Choi KG, Gros P, Housman DE, Fojo A, Shen DW, Gottesman MM, Pastan I (1986) Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 83(12):4538–4542

Saab AM, Gambari R, Sacchetti G, Guerrini A, Lampronti I, Tacchini M, El Samrani A, Medawar S, Makhlouf H, Tannoury M, Abboud J, Diab-Assaf M, Kijjoa A, Tundis R, Aoun J, Efferth T (2018) Phytochemical and pharmacological properties of essential oils from Cedrus species. Nat Prod Res 32(12):1415–1427

Sachs J, Kadioglu O, Weber A, Mundorf V, Betz J, Efferth T, Pietruszka J, Teusch N (2019) Selective inhibition of P-gp transporter by goniothalamin derivatives sensitizes resistant cancer cells to chemotherapy. J Nat Med 73(1):226–235

Saeed M, Khalid H, Sugimoto Y, Efferth T (2014a) The lignan, (-)-sesamin reveals cytotoxicity toward cancer cells: pharmacogenomic determination of genes associated with sensitivity or resistance. Phytomedicine 21(5):689–696

Saeed M, Kuete V, Kadioglu O, Börtzler J, Khalid H, Greten HJ, Efferth T (2014b) Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking. Phytomedicine 21(12):1525–1533

Saeed M, Zeino M, Kadioglu O, Volm M, Efferth T (2014c) Overcoming of P-glycoprotein-mediated multidrug resistance of tumors in vivo by drug combinations. Synergy 1(1):44–58

Saeed M, Jacob S, Sandjo LP, Sugimoto Y, Khalid HE, Opatz T, Thines E, Efferth T (2015a) Cytotoxicity of the sesquiterpene lactones neoambrosin and damsin from Ambrosia maritima against multidrug-resistant cancer cells. Front Pharmacol 6:267

Saeed M, Kadioglu O, Khalid H, Sugimoto Y, Efferth T (2015b) Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking. J Nutr Biochem 26(1):44–56

Saeed ME, Abdelgadir H, Sugimoto Y, Khalid HE, Efferth T (2015c) Cytotoxicity of 35 medicinal plants from Sudan towards sensitive and multidrug-resistant cancer cells. J Ethnopharmacol 174:644–658

Saeed MEM, Meyer M, Hussein A, Efferth T (2016) Cytotoxicity of South-African medicinal plants towards sensitive and multidrug-resistant cancer cells. J Ethnopharmacol 186:209–223

Saeed MEM, Boulos JC, Elhaboub G, Rigano D, Saab A, Loizzo MR, Hassan LEA, Sugimoto Y, Piacente S, Tundis R, Yagi S, Khalid H, Efferth T (2019a) Cytotoxicity of cucurbitacin E from Citrullus colocynthis against multidrug-resistant cancer cells. Phytomedicine 62:152945

Saeed MEM, Rahama M, Kuete V, Dawood M, Elbadawi M, Sugimoto Y, Efferth T (2019b) Collateral sensitivity of drug-resistant ABCB5- and mutation-activated EGFR overexpressing cells towards resveratrol due to modulation of SIRT1 expression. Phytomedicine 59:152890

Safar Z, Kis E, Erdo F, Zolnerciks JK, Krajcsi P (2019) ABCG2/BCRP: variants, transporter interaction profile of substrates and inhibitors. Expert Opin Drug Metab Toxicol 15(4):313–328

Sandjo LP, Fru CG, Kuete V, Nana F, Yeboah SO, Mapitse R, Abegaz BM, Efferth T, Opatz T, Ngadjui BT (2014a) Elatumic acid: a new ursolic acid congener from Omphalocarpum elatum Miers (Sapotaceae). Z Naturforsch C J Biosci 69(7–8):276–282

Sandjo LP, Kuete V, Tchangna RS, Efferth T, Ngadjui BT (2014b) Cytotoxic benzophenanthridine and furoquinoline alkaloids from Zanthoxylum buesgenii (Rutaceae). Chem Cent J 8(1):61

Sandjo LP, Kuete V, Siwe XN, Poumale HMP, Efferth T (2016) Cytotoxicity of an unprecedented brominated oleanolide and a new furoceramide from the Cameroonian spice, Echinops giganteus. Nat Prod Res 30(22):2529–2537

Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C, Fuhlbrigge RC, Kupper TS, Sayegh MH, Frank MH (2008) Identification of cells initiating human melanomas. Nature 451(7176):345–349

Schmidt F, Efferth T (2016) Tumor heterogeneity, single-cell sequencing, and drug resistance. Pharmaceuticals (Basel) 9(2):E33

Seo EJ, Saeed M, Law BY, Wu AG, Kadioglu O, Greten HJ, Efferth T (2016) Pharmacogenomics of scopoletin in tumor cells. Molecules 21(4):496

Seupel R, Hemberger Y, Feineis D, Xu M, Seo EJ, Efferth T, Bringmann G (2018) Ancistrocyclinones A and B, unprecedented pentacyclic N, C-coupled naphthylisoquinoline alkaloids, from the Chinese liana Ancistrocladus tectorius. Org Biomol Chem 16(9):1581–1590

Shanmugam R, Jayaprakasan V, Gokmen-Polar Y, Kelich S, Miller KD, Yip-Schneider M, Cheng L, Bhat-Nakshatri P, Sledge GW Jr, Nakshatri H, Zheng QH, Miller MA, DeGrado T, Hutchins GD, Sweeney CJ (2006) Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model. Prostate 66(14):1498–1511

Sharom FJ, Yu X, DiDiodato G, Chu JW (1996) Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport. Biochem J 320(2):421–428

Siriwatanametanon N, Fiebich BL, Efferth T, Prieto JM, Heinrich M (2010) Traditionally used Thai medicinal plants: in vitro anti-inflammatory, anticancer and antioxidant activities. J Ethnopharmacol 130(2):196–207

Smalley MJ, Clarke RB (2005) The mammary gland “side population”: a putative stem/progenitor cell marker? J Mammary Gland Biol Neoplasia 10(1):37–47

Stockner T, Mullen A, MacMillan F (2015) Investigating the dynamic nature of the ABC transporters: ABCB1 and MsbA as examples for the potential synergies of MD theory and EPR applications. Biochem Soc Trans 43(5):1023–1032

Storch CH, Theile D, Lindenmaier H, Haefeli WE, Weiss J (2007) Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein. Biochem Pharmacol 73(10):1573–1581

Stow MW, Warr JR (1993) Reduced influx is a factor in accounting for reduced vincristine accumulation in certain verapamil-hypersensitive multidrug-resistant CHO cell lines. FEBS Lett 320:87–91

Tacchini M, Spagnoletti A, Marieschi M, Caligiani A, Bruni R, Efferth T, Sacchetti G, Guerrini A (2015) Phytochemical profile and bioactivity of traditional ayurvedic decoctions and hydro-alcoholic macerations of Boerhaavia diffusa L. and Curculigo orchioides Gaertn. Nat Prod Res 29(22):2071–2079

Tamaki A, Ierano C, Szakacs G, Robey RW, Bates SE (2011) The controversial role of ABC transporters in clinical oncology. Essays Biochem 50(1):209–232

Tiwari AK, Sodani K, Wang SR, Kuang YH, Ashby CR, Chen X, Chen ZS (2009) Nilotinib (AMN107, Tasigna) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters. Biochem Pharmacol 78(2):153–161

To KKW, Wu X, Yin C, Chai S, Yao S, Kadioglu O, Efferth T, Ye Y, Lin G (2017) Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes. J Ethnopharmacol 203:110–119

Toyoda Y, Takada T, Suzuki H (2019) Inhibitors of human ABCG2: from technical background to recent updates with clinical implications. Front Pharmacol 10:208

Trock BJ, Leonessa F, Clarke R (1997) Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance. J Natl Cancer Inst 89(13):917–931

Tshitenge DT, Feineis D, Mudogo V, Kaiser M, Brun R, Seo EJ, Efferth T, Bringmann G (2018) Mbandakamine-type naphthylisoquinoline dimers and related alkaloids from the central African liana Ancistrocladus ealaensis with antiparasitic and antileukemic activities. J Nat Prod 81(4):918–933

Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41(5):1967–1972

Uhlig J, Case MD, Blasberg JD, Boffa DJ, Chiang A, Gettinger SN, Kim HS (2019) Comparison of survival rates after a combination of local treatment and systemic therapy vs systemic therapy alone for treatment of stage IV non-small cell lung cancer. JAMA Netw Open 2(8):e199702

Volm M, Kästel M, Mattern J, Efferth T (1993) Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas. Cancer 71(12):3981–3987

Volm M, Koomägi R, Mattern J, Efferth T (2002) Protein expression profiles indicative for drug resistance of non-small cell lung cancer. Br J Cancer 87(3):251–257

Volm M, Koomagi R, Efferth T (2004) Prediction of drug sensitivity and resistance of cancer by protein expression profiling. Cancer Genom Proteom 1(2):157–166

Wang J, Zheng Y, Efferth T, Wang R, Shen Y, Hao X (2005) Indole and carbazole alkaloids from Glycosmis montana with weak anti-HIV and cytotoxic activities. Phytochemistry 66(6):697–701

Warr JR, Anderson M, Fergusson J (1988) Properties of verapamil-hypersensitive multidrug-resistant Chinese hamster ovary cells. Cancer Res 48:4477–4483

Watson MB, Lind MJ, Cawkwell L (2007) Establishment of in vitro models of chemotherapy resistance. Anticancer Drugs 18(7):749–754

Wiese M (2015) BCRP/ABCG2 inhibitors: a patent review (2009-present). Expert Opin Ther Pat 25(11):1229–1237

Wilson BJ, Schatton T, Zhan Q, Gasser M, Ma J, Saab KR, Schanche R, Waaga-Gasser AM, Gold JS, Huang Q, Murphy GF, Frank MH, Frank NY (2011) ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients. Cancer Res 71(15):5307–5316

Wilson BJ, Saab KR, Ma J, Schatton T, Pütz P, Zhan Q, Murphy GF, Gasser M, Waaga-Gasser AM, Frank NY, Frank MH (2014) ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit. Cancer Res 74(15):4196–4207

Wu CF, Efferth T (2015) Miltirone induces G2/M cell cycle arrest and apoptosis in CCRF-CEM acute lymphoblastic leukemia cells. J Nat Prod 78(6):1339–1347

Wu CF, Hong C, Klauck SM, Lin YL, Efferth T (2015) Molecular mechanisms of rosmarinic acid from Salvia miltiorrhiza in acute lymphoblastic leukemia cells. J Ethnopharmacol 176:55–68

Wu CF, Bohnert S, Thines E, Efferth T (2016a) Cytotoxicity of Salvia miltiorrhiza against multidrug-resistant cancer cells. Am J Chin Med 44(4):871–894

Wu CF, Klauck SM, Efferth T (2016b) Anticancer activity of cryptotanshinone on acute lymphoblastic leukemia cells. Arch Toxicol 90(9):2275–2286

Xu SW, Law BYK, Qu SLQ, Hamdoun S, Chen J, Zhang W, Guo JR, Wu AG, Mok SWF, Zhang DW, Xia CL, Sugimoto Y, Efferth T, Liu L, Wong VKW (2020) SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells. Pharmacol Res 153:104660

Yoshimatsu K, Yamaguchi A, Yoshino H, Koyanagi N, Kitoh K (1997) Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin. Cancer Res 57(15):3208–3213

Zeino M, Saeed ME, Kadioglu O, Efferth T (2014) The ability of molecular docking to unravel the controversy and challenges related to P-glycoprotein—a well-known, yet poorly understood drug transporter. Invest New Drugs 32(4):618–625

Zeino M, Brenk R, Gruber L, Zehl M, Urban E, Kopp B, Efferth T (2015a) Cytotoxicity of cardiotonic steroids in sensitive and multidrug-resistant leukemia cells and the link with Na+/K+-ATPase. J Steroid Biochem Mol Biol 150:97–111

Zeino M, Paulsen MS, Zehl M, Urban E, Kopp B, Efferth T (2015b) Identification of new P-glycoprotein inhibitors derived from cardiotonic steroids. Biochem Pharmacol 93(1):11–24

Zhang L, Ma S (2010) Efflux pump inhibitors: a strategy to combat P-glycoprotein and the NorA multidrug resistance pump. ChemMedChem 5(6):811–822